Search research articles
Contact Us
Filters
Showing results (21-30 of 1,603) with videos related to
Page
of 161
Sort By:
ACS Chemical Neuroscience
|
December 10, 2016
ACS Editors' Choice: Providing Recognition to Authors and Open Access to the Community
Craig W Lindsley
ACS Chemical Neuroscience
|
August 17, 2012
The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics
Craig W Lindsley
ACS Chemical Neuroscience
|
July 11, 2012
The top prescription drugs of 2009 in the US: CNS therapeutics rank among highest grossing
Craig W Lindsley
ACS Chemical Neuroscience
|
July 11, 2012
(S)-(+)-mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for Major Depressive Disorder (MDD)
Craig W Lindsley
ACS Chemical Neuroscience
|
July 11, 2012
The top prescription drugs of 2010 in the United States: antipsychotics show strong growth
Craig W Lindsley
Journal of Applied Behavior Analysis
|
April 1, 1992
Why aren't effective teaching tools widely adopted?
O R Lindsley
Journal of the Experimental Analysis of Behavior
|
November 1, 1987
Collecting the first dollars for JEAB
O R Lindsley
ACS Chemical Neuroscience
|
March 21, 2013
New hope for multiple sclerosis patients
Craig W Lindsley
ACS Chemical Neuroscience
|
December 22, 2012
ACS Chemical Neuroscience and neuroscience drug discovery as 2012 comes to a close
Craig W Lindsley
ACS Chemical Neuroscience
|
July 18, 2013
A new impact factor and new directions for ACS Chemical Neuroscience
Craig W Lindsley
Page
of 161
Search research articles
Search
Showing results (21-30 of 1,603) with videos related to
Sort By:
Page
of 161
ACS Chemical Neuroscience
|
December 10, 2016
ACS Editors' Choice: Providing Recognition to Authors and Open Access to the Community
Craig W Lindsley
ACS Chemical Neuroscience
|
August 17, 2012
The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics
Craig W Lindsley
ACS Chemical Neuroscience
|
July 11, 2012
The top prescription drugs of 2009 in the US: CNS therapeutics rank among highest grossing
Craig W Lindsley
ACS Chemical Neuroscience
|
July 11, 2012
(S)-(+)-mecamylamine (TC-5214): a neuronal nicotinic receptor modulator enters phase III trials as an adjunct treatment for Major Depressive Disorder (MDD)
Craig W Lindsley
ACS Chemical Neuroscience
|
July 11, 2012
The top prescription drugs of 2010 in the United States: antipsychotics show strong growth
Craig W Lindsley
Journal of Applied Behavior Analysis
|
April 1, 1992
Why aren't effective teaching tools widely adopted?
O R Lindsley
Journal of the Experimental Analysis of Behavior
|
November 1, 1987
Collecting the first dollars for JEAB
O R Lindsley
ACS Chemical Neuroscience
|
March 21, 2013
New hope for multiple sclerosis patients
Craig W Lindsley
ACS Chemical Neuroscience
|
December 22, 2012
ACS Chemical Neuroscience and neuroscience drug discovery as 2012 comes to a close
Craig W Lindsley
ACS Chemical Neuroscience
|
July 18, 2013
A new impact factor and new directions for ACS Chemical Neuroscience
Craig W Lindsley
Page
of 161